| International AIDS Society global scientific strategy: towards an HIV cure 2016 SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ... Nature medicine 22 (8), 839-850, 2016 | 489 | 2016 |
| Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases TJ Henrich, E Hanhauser, FM Marty, MN Sirignano, S Keating, TH Lee, ... Annals of internal medicine 161 (5), 319-327, 2014 | 487 | 2014 |
| HIV-1 persistence in CD4+ T cells with stem cell–like properties MJ Buzon, H Sun, C Li, A Shaw, K Seiss, Z Ouyang, E Martin-Gayo, ... Nature medicine 20 (2), 139-142, 2014 | 479 | 2014 |
| Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation TJ Henrich, Z Hu, JZ Li, G Sciaranghella, MP Busch, SM Keating, ... The Journal of infectious diseases 207 (11), 1694-1702, 2013 | 322 | 2013 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 309 | 2023 |
| Clinical risk factors for severe Clostridium difficile–associated disease TJ Henrich, D Krakower, A Bitton, DS Yokoe Emerging infectious diseases 15 (3), 415, 2009 | 290 | 2009 |
| HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study TJ Henrich, H Hatano, O Bacon, LE Hogan, R Rutishauser, A Hill, ... PLoS medicine 14 (11), e1002417, 2017 | 233 | 2017 |
| Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection MJ Peluso, S Lu, AF Tang, MS Durstenfeld, H Ho, SA Goldberg, ... The Journal of infectious diseases 224 (11), 1839-1848, 2021 | 219 | 2021 |
| Nanostructured optical photonic crystal biosensor for HIV viral load measurement H Shafiee, EA Lidstone, M Jahangir, F Inci, E Hanhauser, TJ Henrich, ... Scientific reports 4 (1), 4116, 2014 | 186 | 2014 |
| Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR TJ Henrich, S Gallien, JZ Li, F Pereyra, DR Kuritzkes Journal of virological methods 186 (1-2), 68-72, 2012 | 184 | 2012 |
| HIV-1 entry inhibitors: recent development and clinical use TJ Henrich, DR Kuritzkes Current opinion in virology 3 (1), 51-57, 2013 | 179 | 2013 |
| Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy MJ Peluso, P Bacchetti, KD Ritter, S Beg, J Lai, JN Martin, PW Hunt, ... JCI insight 5 (4), 2020 | 166 | 2020 |
| Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations B Sun, N Tang, MJ Peluso, NS Iyer, L Torres, JL Donatelli, SE Munter, ... Cells 10 (2), 386, 2021 | 165 | 2021 |
| Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms MJ Peluso, AN Deitchman, L Torres, NS Iyer, SE Munter, CC Nixon, ... Cell Reports 36 (6), 2021 | 163 | 2021 |
| Designing and interpreting limiting dilution assays: general principles and applications to the latent reservoir for human immunodeficiency virus-1 DIS Rosenbloom, O Elliott, AL Hill, TJ Henrich, JM Siliciano, RF Siliciano Open forum infectious diseases 2 (4), ofv123, 2015 | 154 | 2015 |
| Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients J Hellmuth, TA Barnett, BM Asken, JD Kelly, L Torres, ML Stephens, ... Journal of neurovirology 27, 191-195, 2021 | 152 | 2021 |
| Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui, K Pance, SA Lim, ... Nature biotechnology 39 (8), 928-935, 2021 | 138 | 2021 |
| SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay MJ Peluso, S Takahashi, J Hakim, JD Kelly, L Torres, NS Iyer, K Turcios, ... Science advances 7 (31), eabh3409, 2021 | 131 | 2021 |
| Emerging technologies for point-of-care management of HIV infection H Shafiee, SQ Wang, F Inci, M Toy, TJ Henrich, DR Kuritzkes, U Demirci Annual review of medicine 66 (1), 387-405, 2015 | 129 | 2015 |
| SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study MA Spinelli, KL Lynch, C Yun, DV Glidden, MJ Peluso, TJ Henrich, ... The lancet HIV 8 (6), e334-e341, 2021 | 116 | 2021 |
